Skip to main content
Top
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Dementia | Research

The impact of the COVID-19 pandemic on mortality in people with dementia without COVID-19: a systematic review and meta-analysis

Authors: Michael Axenhus, Kristian Steen Frederiksen, Robin Ziyue Zhou, Gunhild Waldemar, Bengt Winblad

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Introduction

Significant mortality amongst vulnerable populations, such as people living with dementia, might go undetected during pandemic conditions due to refocus of care efforts. There is an urgent need to fully evaluate the pandemic impact on mortality amongst people living with dementia in order to facilitate future healthcare reforms and prevent deaths. The purpose of this study was to determine whether there was any significant difference in mortality amongst people with dementia without COVID-19 during the COVID-19 pandemic compared to previous years.

Methods

A literature search was conducted in 5 databases. The relative risk ratio and confidence interval was used to estimate the change in mortality rates amongst people with dementia during the COVID-19 pandemic. The I2 value was used to assess heterogeneity, publication bias, and sensitivity analyses were performed.

Results

Pooled analysis of 11 studies showed that mortality amongst people living with dementia was significantly increased during the COVID-19 pandemic for people with dementia without COVID-19. Mortality risk increased by 25% during the time period studied. Subgroup analysis was not performed due the low number of included studies.

Conclusions

The results of this study suggest that people with dementia had a significant increased mortality during the pandemic even if they did not have COVID-19. People with dementia should participate in efforts that reduce general social spread and pandemic impact on healthcare system such as vaccinations, mask mandates, and testing. These results have clinical implications as preventing direct COVID-19 infection is not enough to adequately protect people living with dementia from increased mortality. Measures to limit social spread of infections and help support patients should also be a focus for clinicians. Further research should focus on the identification of mechanisms and other explanations for increased mortality as well as contributing factors such as living in care homes and differences between countries with various pandemic strategies.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72(2):340–50.PubMedCrossRef Fung M, Babik JM. COVID-19 in immunocompromised hosts: what we know so far. Clin Infect Dis. 2021;72(2):340–50.PubMedCrossRef
3.
go back to reference Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID-19 and older adults: what we know. J Am Geriatr Soc. 2020;68(5):926–9.PubMedPubMedCentralCrossRef Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID-19 and older adults: what we know. J Am Geriatr Soc. 2020;68(5):926–9.PubMedPubMedCentralCrossRef
4.
go back to reference Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.PubMedPubMedCentralCrossRef Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5.PubMedPubMedCentralCrossRef
5.
go back to reference Tehrani S, Killander A, Åstrand P, Jakobsson J, Gille-Johnson P. Risk factors for death in adult COVID-19 patients: frailty predicts fatal outcome in older patients. Int J Infect Dis. 2021;102:415–21.PubMedCrossRef Tehrani S, Killander A, Åstrand P, Jakobsson J, Gille-Johnson P. Risk factors for death in adult COVID-19 patients: frailty predicts fatal outcome in older patients. Int J Infect Dis. 2021;102:415–21.PubMedCrossRef
6.
go back to reference Singhal S, Kumar P, Singh S, Saha S, Dey AB. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):321.PubMedPubMedCentralCrossRef Singhal S, Kumar P, Singh S, Saha S, Dey AB. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):321.PubMedPubMedCentralCrossRef
7.
go back to reference Hägg S, Jylhävä J, Wang Y, Xu H, Metzner C, Annetorp M, et al. Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care. J Am Med Dir Assoc. 2020;21(11):1555–1559.e2.PubMedPubMedCentralCrossRef Hägg S, Jylhävä J, Wang Y, Xu H, Metzner C, Annetorp M, et al. Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care. J Am Med Dir Assoc. 2020;21(11):1555–1559.e2.PubMedPubMedCentralCrossRef
8.
go back to reference Mancilla-Galindo J, Kammar-García A, Martínez-Esteban A, Meza-Comparán HD, Mancilla-Ramírez J, Galindo-Sevilla N. COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms. Epidemiol Infect. 2021;22(149):e230.CrossRef Mancilla-Galindo J, Kammar-García A, Martínez-Esteban A, Meza-Comparán HD, Mancilla-Ramírez J, Galindo-Sevilla N. COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms. Epidemiol Infect. 2021;22(149):e230.CrossRef
10.
go back to reference Sorrell JM. Losing a generation: the impact of COVID-19 on older Americans. J Psychosoc Nurs Ment Health Serv. 2021;59(4):9–12.PubMedCrossRef Sorrell JM. Losing a generation: the impact of COVID-19 on older Americans. J Psychosoc Nurs Ment Health Serv. 2021;59(4):9–12.PubMedCrossRef
11.
go back to reference Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959–81.CrossRef Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY). 2020;12(10):9959–81.CrossRef
12.
go back to reference Hariyanto TI, Putri C, Arisa J, Situmeang RFV, Kurniawan A. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2021;93:104299.PubMedCrossRef Hariyanto TI, Putri C, Arisa J, Situmeang RFV, Kurniawan A. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis. Arch Gerontol Geriatr. 2021;93:104299.PubMedCrossRef
13.
14.
go back to reference Pisaturo M, Calò F, Russo A, Camaioni C, Giaccone A, Pinchera B, et al. Dementia as risk factor for severe coronavirus disease 2019: a case-control study. Front Aging Neurosci. 2021;13:698184.PubMedPubMedCentralCrossRef Pisaturo M, Calò F, Russo A, Camaioni C, Giaccone A, Pinchera B, et al. Dementia as risk factor for severe coronavirus disease 2019: a case-control study. Front Aging Neurosci. 2021;13:698184.PubMedPubMedCentralCrossRef
15.
go back to reference Pécout C, Pain E, Chekroun M, Champeix C, Kulak C, Prieto R, et al. Impact of the COVID-19 pandemic on patients affected by non-communicable diseases in Europe and in the USA. Int J Environ Res Public Health. 2021;18(13):6697.PubMedPubMedCentralCrossRef Pécout C, Pain E, Chekroun M, Champeix C, Kulak C, Prieto R, et al. Impact of the COVID-19 pandemic on patients affected by non-communicable diseases in Europe and in the USA. Int J Environ Res Public Health. 2021;18(13):6697.PubMedPubMedCentralCrossRef
16.
17.
go back to reference Axenhus M, Schedin-Weiss S, Winblad B, Wimo A. Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden. Scand J Public Health. 2021;21:140349482110646. Axenhus M, Schedin-Weiss S, Winblad B, Wimo A. Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden. Scand J Public Health. 2021;21:140349482110646.
18.
go back to reference Fitzpatrick JM, Rafferty AM, Hussein S, Ezhova I, Palmer S, Adams R, et al. Protecting older people living in care homes from COVID-19: a protocol for a mixed-methods study to understand the challenges and solutions to implementing social distancing and isolation. BMJ Open. 2021;11(8):e050706.PubMedCrossRef Fitzpatrick JM, Rafferty AM, Hussein S, Ezhova I, Palmer S, Adams R, et al. Protecting older people living in care homes from COVID-19: a protocol for a mixed-methods study to understand the challenges and solutions to implementing social distancing and isolation. BMJ Open. 2021;11(8):e050706.PubMedCrossRef
19.
go back to reference Giebel C, Hanna K, Cannon J, Shenton J, Mason S, Tetlow H, et al. Taking the ‘care’ out of care homes: the moral dilemma of institutional long-term care provision during COVID-19. Health Soc Care Community. 2021;30(5):e2127.PubMed Giebel C, Hanna K, Cannon J, Shenton J, Mason S, Tetlow H, et al. Taking the ‘care’ out of care homes: the moral dilemma of institutional long-term care provision during COVID-19. Health Soc Care Community. 2021;30(5):e2127.PubMed
20.
go back to reference Czeisler MÉ, Marynak K, Clarke KEN, Salah Z, Shakya I, Thierry JM, et al. Delay or avoidance of medical care because of COVID-19–related concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–7.PubMedPubMedCentralCrossRef Czeisler MÉ, Marynak K, Clarke KEN, Salah Z, Shakya I, Thierry JM, et al. Delay or avoidance of medical care because of COVID-19–related concerns — United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(36):1250–7.PubMedPubMedCentralCrossRef
21.
go back to reference Stall NM, Jones A, Brown KA, Rochon PA, Costa AP. For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths. CMAJ. 2020;192(33):E946–55.PubMedPubMedCentralCrossRef Stall NM, Jones A, Brown KA, Rochon PA, Costa AP. For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths. CMAJ. 2020;192(33):E946–55.PubMedPubMedCentralCrossRef
22.
23.
go back to reference Axenhus M, Schedin-Weiss S, Tjernberg L, Wimo A, Eriksdotter M, Bucht G, et al. Changes in dementia diagnoses in Sweden during the COVID-19 pandemic. BMC Geriatr. 2022;22(1):365.PubMedPubMedCentralCrossRef Axenhus M, Schedin-Weiss S, Tjernberg L, Wimo A, Eriksdotter M, Bucht G, et al. Changes in dementia diagnoses in Sweden during the COVID-19 pandemic. BMC Geriatr. 2022;22(1):365.PubMedPubMedCentralCrossRef
24.
go back to reference Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:n71.CrossRef Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:n71.CrossRef
26.
go back to reference Wood J. Methodology for dealing with duplicate study effects in a Meta-analysis. Organ Res Methods. 2008;11(1):79–95.CrossRef Wood J. Methodology for dealing with duplicate study effects in a Meta-analysis. Organ Res Methods. 2008;11(1):79–95.CrossRef
27.
go back to reference Abou-Setta AM, Beaupre LA, Jones CA, Rashiq S, Hamm MP, Sadowski CA, et al. Newcastle-Ottawa Scale Assessment of Cohort Studies [Internet]. Pain Management Interventions for Hip Fracture [Internet]. Agency for Healthcare Research and Quality (US); 2011 [cited 2022 Apr 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK56664/ Abou-Setta AM, Beaupre LA, Jones CA, Rashiq S, Hamm MP, Sadowski CA, et al. Newcastle-Ottawa Scale Assessment of Cohort Studies [Internet]. Pain Management Interventions for Hip Fracture [Internet]. Agency for Healthcare Research and Quality (US); 2011 [cited 2022 Apr 20]. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK56664/​
28.
go back to reference Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.PubMedPubMedCentralCrossRef Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.PubMedPubMedCentralCrossRef
29.
go back to reference Zhang J, Yu KF. What’s the relative risk?: a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690.PubMedCrossRef Zhang J, Yu KF. What’s the relative risk?: a method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690.PubMedCrossRef
31.
go back to reference Strongman H, Carreira H, De Stavola BL, Bhaskaran K, Leon DA. Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. PLoS Med. 2022;19(1):e1003870.PubMedPubMedCentralCrossRef Strongman H, Carreira H, De Stavola BL, Bhaskaran K, Leon DA. Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. PLoS Med. 2022;19(1):e1003870.PubMedPubMedCentralCrossRef
32.
go back to reference Das-Munshi J, Chang CK, Bakolis I, Broadbent M, Dregan A, Hotopf M, et al. All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study. The Lancet Regional Health - Europe. 2021;11:100228.PubMedPubMedCentralCrossRef Das-Munshi J, Chang CK, Bakolis I, Broadbent M, Dregan A, Hotopf M, et al. All-cause and cause-specific mortality in people with mental disorders and intellectual disabilities, before and during the COVID-19 pandemic: cohort study. The Lancet Regional Health - Europe. 2021;11:100228.PubMedPubMedCentralCrossRef
33.
go back to reference Grande E, Fedeli U, Pappagallo M, Crialesi R, Marchetti S, Minelli G, et al. Variation in cause-specific mortality rates in Italy during the first wave of the COVID-19 pandemic: a study based on Nationwide data. IJERPH. 2022;19(2):805.PubMedPubMedCentralCrossRef Grande E, Fedeli U, Pappagallo M, Crialesi R, Marchetti S, Minelli G, et al. Variation in cause-specific mortality rates in Italy during the first wave of the COVID-19 pandemic: a study based on Nationwide data. IJERPH. 2022;19(2):805.PubMedPubMedCentralCrossRef
34.
go back to reference Fedeli U, Schievano E, Avossa F, Pitter G, Barbiellini Amidei C, Grande E, et al. Different approaches to the analysis of causes of death during the COVID-19 epidemic. Eur Rev Med Pharmacol Sci. 2021;25(9):3610–3.PubMed Fedeli U, Schievano E, Avossa F, Pitter G, Barbiellini Amidei C, Grande E, et al. Different approaches to the analysis of causes of death during the COVID-19 epidemic. Eur Rev Med Pharmacol Sci. 2021;25(9):3610–3.PubMed
35.
go back to reference Raknes G, Strøm MS, Sulo G, Øverland S, Roelants M, Juliusson PB. Lockdown and non-COVID-19 deaths: cause-specific mortality during the first wave of the 2020 pandemic in Norway: a population-based register study. BMJ Open. 2021;11(12):e050525.PubMedCrossRef Raknes G, Strøm MS, Sulo G, Øverland S, Roelants M, Juliusson PB. Lockdown and non-COVID-19 deaths: cause-specific mortality during the first wave of the 2020 pandemic in Norway: a population-based register study. BMJ Open. 2021;11(12):e050525.PubMedCrossRef
36.
go back to reference Shiels MS, Almeida JS, García-Closas M, Albert PS, Freedman ND, de González AB. Impact of population growth and aging on estimates of excess U.S. deaths during the COVID-19 pandemic, march to august 2020. Ann Intern Med. 2021 Apr;174(4):437–43.PubMedCrossRef Shiels MS, Almeida JS, García-Closas M, Albert PS, Freedman ND, de González AB. Impact of population growth and aging on estimates of excess U.S. deaths during the COVID-19 pandemic, march to august 2020. Ann Intern Med. 2021 Apr;174(4):437–43.PubMedCrossRef
37.
go back to reference Gilstrap L, Zhou W, Alsan M, Nanda A, Skinner JS. Trends in mortality rates among Medicare enrollees with Alzheimer disease and related dementias before and during the early phase of the COVID-19 pandemic. JAMA Neurol. 2022;79(4):342.PubMedCrossRef Gilstrap L, Zhou W, Alsan M, Nanda A, Skinner JS. Trends in mortality rates among Medicare enrollees with Alzheimer disease and related dementias before and during the early phase of the COVID-19 pandemic. JAMA Neurol. 2022;79(4):342.PubMedCrossRef
38.
go back to reference Lee WE, Park SW, Weinberger DM, Olson D, Simonsen L, Grenfell BT, et al. Direct and indirect mortality impacts of the COVID-19 pandemic in the US, March 2020–April 2021: medRxiv; 2022. 2022.02.10.22270721CrossRef Lee WE, Park SW, Weinberger DM, Olson D, Simonsen L, Grenfell BT, et al. Direct and indirect mortality impacts of the COVID-19 pandemic in the US, March 2020–April 2021: medRxiv; 2022. 2022.02.10.22270721CrossRef
39.
go back to reference Reif J, Heun-Johnson H, Tysinger B, Lakdawalla D. Measuring the COVID-19 mortality burden in the United States: a microsimulation study. Ann Intern Med. 2021;174(12):1700–9.PubMedCrossRef Reif J, Heun-Johnson H, Tysinger B, Lakdawalla D. Measuring the COVID-19 mortality burden in the United States: a microsimulation study. Ann Intern Med. 2021;174(12):1700–9.PubMedCrossRef
40.
go back to reference Carey IM, Cook DG, Harris T, DeWilde S, Chaudhry UAR, Strachan DP. Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in England: A retrospective cohort study of primary care data. PLoS ONE. 2021;16(12):e0260381.PubMedPubMedCentralCrossRef Carey IM, Cook DG, Harris T, DeWilde S, Chaudhry UAR, Strachan DP. Risk factors for excess all-cause mortality during the first wave of the COVID-19 pandemic in England: A retrospective cohort study of primary care data. PLoS ONE. 2021;16(12):e0260381.PubMedPubMedCentralCrossRef
41.
go back to reference Taudorf L, Nørgaard A, Waldemar G, Laursen TM. Mortality in dementia from 1996 to 2015: a National Registry-Based Cohort Study. J Alzheimers Dis. 2021;79(1):289–300.PubMedPubMedCentralCrossRef Taudorf L, Nørgaard A, Waldemar G, Laursen TM. Mortality in dementia from 1996 to 2015: a National Registry-Based Cohort Study. J Alzheimers Dis. 2021;79(1):289–300.PubMedPubMedCentralCrossRef
42.
go back to reference Manca R, De Marco M, Colston A, Raymont V, Amin J, Davies R, et al. The impact of social isolation due to COVID-19 on symptom progression in people with dementia: findings of the SOLITUDE study. Front Psychiatry. 2022;13:877595.PubMedPubMedCentralCrossRef Manca R, De Marco M, Colston A, Raymont V, Amin J, Davies R, et al. The impact of social isolation due to COVID-19 on symptom progression in people with dementia: findings of the SOLITUDE study. Front Psychiatry. 2022;13:877595.PubMedPubMedCentralCrossRef
43.
go back to reference Goldberg TE, Choi J, Lee S, Gurland B, Devanand DP. Effects of restriction of activities and social isolation on risk of dementia in the community. Int Psychogeriatr. 2021;33(11):1207–15.PubMedCrossRef Goldberg TE, Choi J, Lee S, Gurland B, Devanand DP. Effects of restriction of activities and social isolation on risk of dementia in the community. Int Psychogeriatr. 2021;33(11):1207–15.PubMedCrossRef
44.
go back to reference Nørgaard A, Jensen-Dahm C, Wimberley T, Svendsen JH, Ishtiak-Ahmed K, Laursen TM, et al. Effect of antipsychotics on mortality risk in patients with dementia with and without comorbidities. J American Geriatrics Society. 2022;70(4):1169–79.CrossRef Nørgaard A, Jensen-Dahm C, Wimberley T, Svendsen JH, Ishtiak-Ahmed K, Laursen TM, et al. Effect of antipsychotics on mortality risk in patients with dementia with and without comorbidities. J American Geriatrics Society. 2022;70(4):1169–79.CrossRef
45.
go back to reference Chirico I, Pappadà A, Giebel C, Ottoboni G, Valente M, Gabbay M, et al. The impact of COVID-19 restrictions and care home strategies on residents with dementia as experienced by family carers in Italy. Aging Ment Health. 2022;25:1–9.CrossRef Chirico I, Pappadà A, Giebel C, Ottoboni G, Valente M, Gabbay M, et al. The impact of COVID-19 restrictions and care home strategies on residents with dementia as experienced by family carers in Italy. Aging Ment Health. 2022;25:1–9.CrossRef
46.
go back to reference Hoel V, Seibert K, Domhoff D, Preuß B, Heinze F, Rothgang H, et al. Social health among German nursing home residents with dementia during the COVID-19 pandemic, and the role of technology to promote social participation. Int J Environ Res Public Health. 2022;19(4):1956.PubMedPubMedCentralCrossRef Hoel V, Seibert K, Domhoff D, Preuß B, Heinze F, Rothgang H, et al. Social health among German nursing home residents with dementia during the COVID-19 pandemic, and the role of technology to promote social participation. Int J Environ Res Public Health. 2022;19(4):1956.PubMedPubMedCentralCrossRef
47.
go back to reference Caratozzolo S, Zucchelli A, Turla M, Cotelli MS, Fascendini S, Zanni M, et al. The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network. Aging Clin Exp Res. 2020;32(10):2133–40.PubMedPubMedCentralCrossRef Caratozzolo S, Zucchelli A, Turla M, Cotelli MS, Fascendini S, Zanni M, et al. The impact of COVID-19 on health status of home-dwelling elderly patients with dementia in East Lombardy, Italy: results from COVIDEM network. Aging Clin Exp Res. 2020;32(10):2133–40.PubMedPubMedCentralCrossRef
48.
go back to reference Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–20.PubMedPubMedCentralCrossRef Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–20.PubMedPubMedCentralCrossRef
49.
go back to reference Wei G, Diehl-Schmid J, Matias-Guiu JA, Pijnenburg Y, Landin-Romero R, Bogaardt H, et al. The effects of the COVID-19 pandemic on neuropsychiatric symptoms in dementia and carer mental health: an international multicentre study. Sci Rep. 2022;(1):2418. Wei G, Diehl-Schmid J, Matias-Guiu JA, Pijnenburg Y, Landin-Romero R, Bogaardt H, et al. The effects of the COVID-19 pandemic on neuropsychiatric symptoms in dementia and carer mental health: an international multicentre study. Sci Rep. 2022;(1):2418.
50.
go back to reference Cuadros DF, Moreno CM, Musuka G, Miller FD, Coule P, MacKinnon NJ. Association between vaccination coverage disparity and the dynamics of the COVID-19 Delta and omicron waves in the US. Front Med (Lausanne). 2022;14(9):898101.CrossRef Cuadros DF, Moreno CM, Musuka G, Miller FD, Coule P, MacKinnon NJ. Association between vaccination coverage disparity and the dynamics of the COVID-19 Delta and omicron waves in the US. Front Med (Lausanne). 2022;14(9):898101.CrossRef
51.
go back to reference Rivera-Hernandez M, Ferdows NB, Kumar A. The impact of the COVID-19 epidemic on older adults in rural and urban areas in Mexico. Carr D, editor. The J of Geront: Series B. 2021;76(7):e268–74.CrossRef Rivera-Hernandez M, Ferdows NB, Kumar A. The impact of the COVID-19 epidemic on older adults in rural and urban areas in Mexico. Carr D, editor. The J of Geront: Series B. 2021;76(7):e268–74.CrossRef
52.
go back to reference Rahman M, White EM, Thomas KS, Jutkowitz E. Assessment of rural-urban differences in health care use and survival among Medicare beneficiaries with Alzheimer disease and related dementia. JAMA Netw Open. 2020;3(10):e2022111.PubMedPubMedCentralCrossRef Rahman M, White EM, Thomas KS, Jutkowitz E. Assessment of rural-urban differences in health care use and survival among Medicare beneficiaries with Alzheimer disease and related dementia. JAMA Netw Open. 2020;3(10):e2022111.PubMedPubMedCentralCrossRef
53.
go back to reference Cross SH, Warraich HJ. Rural-urban disparities in mortality from Alzheimer’s and related dementias in the United States, 1999–2018. J Am Geriatr Soc. 2021;69(4):1095–6.PubMedCrossRef Cross SH, Warraich HJ. Rural-urban disparities in mortality from Alzheimer’s and related dementias in the United States, 1999–2018. J Am Geriatr Soc. 2021;69(4):1095–6.PubMedCrossRef
56.
go back to reference See I, Paul P, Slayton RB, Steele MK, Stuckey MJ, Duca L, et al. Modeling effectiveness of testing strategies to prevent coronavirus disease 2019 (COVID-19) in nursing homes-United States, 2020. Clin Infect Dis. 2021;73(3):e792–8.PubMedCrossRef See I, Paul P, Slayton RB, Steele MK, Stuckey MJ, Duca L, et al. Modeling effectiveness of testing strategies to prevent coronavirus disease 2019 (COVID-19) in nursing homes-United States, 2020. Clin Infect Dis. 2021;73(3):e792–8.PubMedCrossRef
57.
go back to reference Adjodah D, Dinakar K, Chinazzi M, Fraiberger SP, Pentland A, Bates S, et al. Association between COVID-19 outcomes and mask mandates, adherence, and attitudes. PLoS One. 2021;16(6):e0252315.PubMedPubMedCentralCrossRef Adjodah D, Dinakar K, Chinazzi M, Fraiberger SP, Pentland A, Bates S, et al. Association between COVID-19 outcomes and mask mandates, adherence, and attitudes. PLoS One. 2021;16(6):e0252315.PubMedPubMedCentralCrossRef
58.
go back to reference Sah P, Vilches TN, Moghadas SM, Fitzpatrick MC, Singer BH, Hotez PJ, et al. Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants. EClinicalMedicine. 2021;35:100865.PubMedPubMedCentralCrossRef Sah P, Vilches TN, Moghadas SM, Fitzpatrick MC, Singer BH, Hotez PJ, et al. Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants. EClinicalMedicine. 2021;35:100865.PubMedPubMedCentralCrossRef
59.
go back to reference the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel, Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, et al. Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care. Bonanni L, editor. JAD. 2021;82(3):883–98.CrossRef the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel, Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, et al. Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care. Bonanni L, editor. JAD. 2021;82(3):883–98.CrossRef
Metadata
Title
The impact of the COVID-19 pandemic on mortality in people with dementia without COVID-19: a systematic review and meta-analysis
Authors
Michael Axenhus
Kristian Steen Frederiksen
Robin Ziyue Zhou
Gunhild Waldemar
Bengt Winblad
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03602-6

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine